Abstract 3347: Developing a prognostic biomarker of EGFR/RAS/SIAH pathway activation/inactivation following neoadjuvant chemotherapy to risk stratify patients, detect racial disparity, and predict relapse and survival in triple-negative breast cancer in Hampton Roads, Virginia | InnScience